New Insights into Nanomaterials for Cancer Therapy and Drug Delivery
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 30 April 2026 | Viewed by 2
Special Issue Editors
Interests: nanomedicine; bioprinting; tissue engineering; multi-organ
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nanotechnology has emerged as a powerful tool to revolutionize cancer therapy and drug delivery, enabling precise targeting, controlled release and reduced systemic toxicity. This Special Issue, “New Insights into Nanomaterials for Cancer Therapy and Drug Delivery”, aims to highlight recent advances in the design, synthesis and functionalization of nanomaterials for oncological applications. Contributions will cover innovative nanocarriers, multifunctional and stimuli-responsive systems, strategies for overcoming biological barriers as well as preclinical and translational studies that bridge the gap toward clinical implementation. By gathering cutting-edge research and critical reviews, this Special Issue seeks to provide a comprehensive overview of how novel nanomaterials can improve therapeutic efficacy, minimize side effects and pave the way for next-generation cancer treatments.
Dr. Giordano Perini
Dr. Antonio Minopoli
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomaterials
- cancer
- targeted therapy
- drug delivery
- new therapeutics
- precision nanomedicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
